Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18708
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

Earnings for BioNexus Gene Lab Corporation (BGLC)
Earnings in Sep 2025 TTM: $-2.37M
According to BioNexus Gene Lab Corporation latest financial reports the company's current earnings are $-2.37M. In 2023 the company made an earning of $-2.61M, a decrease compared to its 2022 earnings that were of $-303.66K. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BioNexus Gene Lab Corporation from 2016 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-2.37M 48.64%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.27B -306,699.14%
US
$4.23B -178,668.26%
US
$1.32B -55,960.65%
US
$2.63B -111,037.93%
CN
$1.43B -60,508.64%
US